Literature DB >> 24395240

Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.

Frédéric Lamoth1, Praveen R Juvvadi, Erik J Soderblom, M Arthur Moseley, Yohannes G Asfaw, William J Steinbach.   

Abstract

Heat shock protein 90 (Hsp90) is an essential chaperone involved in the fungal stress response that can be harnessed as a novel antifungal target for the treatment of invasive aspergillosis. We previously showed that genetic repression of Hsp90 reduced Aspergillus fumigatus virulence and potentiated the effect of the echinocandin caspofungin. In this study, we sought to identify sites of posttranslational modifications (phosphorylation or acetylation) that are important for Hsp90 function in A. fumigatus. Phosphopeptide enrichment and tandem mass spectrometry revealed phosphorylation of three residues in Hsp90 (S49, S288, and T681), but their mutation did not compromise Hsp90 function. Acetylation of lysine residues of Hsp90 was recovered after treatment with deacetylase inhibitors, and acetylation-mimetic mutations (K27A and K271A) resulted in reduced virulence in a murine model of invasive aspergillosis, supporting their role in Hsp90 function. A single deletion of lysine K27 or an acetylation-mimetic mutation (K27A) resulted in increased susceptibility to voriconazole and caspofungin. This effect was attenuated following a deacetylation-mimetic mutation (K27R), suggesting that this site is crucial and should be deacetylated for proper Hsp90 function in antifungal resistance pathways. In contrast to previous reports in Candida albicans, the lysine deacetylase inhibitor trichostatin A (TSA) was active alone against A. fumigatus and potentiated the effect of caspofungin against both the wild type and an echinocandin-resistant strain. Our results indicate that the Hsp90 K27 residue is required for azole and echinocandin resistance in A. fumigatus and that deacetylase inhibition may represent an adjunctive anti-Aspergillus strategy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395240      PMCID: PMC4023766          DOI: 10.1128/AAC.02286-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Differential expression of the Aspergillus fumigatus pksP gene detected in vitro and in vivo with green fluorescent protein.

Authors:  K Langfelder; B Philippe; B Jahn; J P Latgé; A A Brakhage
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.

Authors:  W Lamar Smith; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Demethylase activity is directed by histone acetylation.

Authors:  N Cervoni; M Szyf
Journal:  J Biol Chem       Date:  2001-08-27       Impact factor: 5.157

4.  Isolation and partial characterization of Hsp90 from Candida albicans.

Authors:  Edward T Burt; Rhona Daly; Deana Hoganson; Yuri Tsirulnikov; Michael Essmann; Bryan Larsen
Journal:  Ann Clin Lab Sci       Date:  2003       Impact factor: 1.256

5.  Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.

Authors:  Xiaodan Yu; Z Sheng Guo; Monica G Marcu; Len Neckers; Dao M Nguyen; G Aaron Chen; David S Schrump
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

6.  Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in Aspergillus fumigatus.

Authors:  Frédéric Lamoth; Praveen R Juvvadi; Christopher Gehrke; Yohannes G Asfaw; William J Steinbach
Journal:  J Infect Dis       Date:  2013-10-04       Impact factor: 5.226

7.  Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.

Authors:  Yan-Hsiung Wang; Yeou-Guang Tsay; Bertrand Chin-Ming Tan; Wen-Yi Lo; Sheng-Chung Lee
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

8.  Histone deacetylases in fungi: novel members, new facts.

Authors:  Patrick Trojer; Eva M Brandtner; Gerald Brosch; Peter Loidl; Johannes Galehr; Roland Linzmaier; Hubertus Haas; Karin Mair; Martin Tribus; Stefan Graessle
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

9.  Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.

Authors:  Ramadevi Nimmanapalli; Lianne Fuino; Purva Bali; Maura Gasparetto; Michele Glozak; Jianguo Tao; Lynn Moscinski; Clayton Smith; Jie Wu; Richard Jove; Peter Atadja; Kapil Bhalla
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

10.  Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

Authors:  M A Pfaller; S A Messer; N Georgopapadakou; L A Martell; J M Besterman; D J Diekema
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

View more
  34 in total

Review 1.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

Review 2.  Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.

Authors:  Marion Aruanno; Emmanouil Glampedakis; Frédéric Lamoth
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 3.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

4.  Histone deacetylases: Targets for antifungal drug development.

Authors:  Livia Kmetzsch
Journal:  Virulence       Date:  2015-07-07       Impact factor: 5.882

Review 5.  Epigenetic mechanisms of drug resistance in fungi.

Authors:  Zanetta Chang; Vikas Yadav; Soo Chan Lee; Joseph Heitman
Journal:  Fungal Genet Biol       Date:  2019-07-17       Impact factor: 3.495

Review 6.  The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.

Authors:  Xiaolei Wei; Yuanwei Zhang; Ling Lu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

7.  The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.

Authors:  Veronika Loiko; Johannes Wagener
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

8.  Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes.

Authors:  Fabiana As Brandão; Lorena S Derengowski; Patrícia Albuquerque; André M Nicola; Ildinete Silva-Pereira; Marcio J Poças-Fonseca
Journal:  Virulence       Date:  2015-06-23       Impact factor: 5.882

Review 9.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 10.  Lysine acetylation as drug target in fungi: an underexplored potential in Aspergillus spp.

Authors:  Natália Sayuri Wassano; Ariely Barbosa Leite; Franqueline Reichert-Lima; Angelica Zaninelli Schreiber; Nilmar S Moretti; André Damasio
Journal:  Braz J Microbiol       Date:  2020-03-13       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.